Siphonaxanthin, a Carotenoid From Green Algae, Inhibits Lipogenesis in Hepatocytes via the Suppression of Liver X Receptor α Activity

Lutein Prevents High Fat Diet-Induced Atherosclerosis in ApoE-Deficient Mice by Inhibiting NADPH Oxidase and Increasing PPAR Expression

(2015) Hao Han et al.   LIPIDS

Gut Microbial Fatty Acid Metabolites Reduce Triacylglycerol Levels in Hepatocytes

(2015) Tharnath Nanthirudjanar et al.   LIPIDS

Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E

(2015) Yinhua Ni et al.   Scientific Reports

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis

(2015) Kristine Griffett et al.   Molecular Metabolism

Hepatic PPARγ and LXRα independently regulate lipid accumulation in the livers of genetically obese mice

(2014) Kimihiko Matsusue et al.   FEBS LETTERS

Ring finger protein20 regulates hepatic lipid metabolism through protein kinase A-dependent sterol regulatory element binding protein1c degradation

(2014) Jae Ho Lee et al.   HEPATOLOGY

The Green Algal Carotenoid Siphonaxanthin Inhibits Adipogenesis in 3T3-L1 Preadipocytes and the Accumulation of Lipids in White Adipose Tissue of KK-Ay Mice

(2014) Zhuo-Si Li et al.   JOURNAL OF NUTRITION

Suppressive Effects of Carotenoids on the Antigen-induced Degranulation in RBL-2H3 Rat Basophilic Leukemia Cells

(2014) Yuki Manabe et al.   Journal of Oleo Science

Siphonaxanthin, a Green Algal Carotenoid, as a Novel Functional Compound

(2014) Tatsuya Sugawara et al.   Marine Drugs

β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice

(2014) Masuko Kobori et al.   PLoS One

Regulation of Insulin Resistance and Adiponectin Signaling in Adipose Tissue by Liver X Receptor Activation Highlights a Cross-Talk with PPARγ

(2014) Fenping Zheng et al.   PLoS One

Zeaxanthin Dipalmitate Therapeutically Improves Hepatic Functions in an Alcoholic Fatty Liver Disease Model through Modulating MAPK Pathway

(2014) Jia Xiao et al.   PLoS One

The effect of fucoxanthin rich power on the lipid metabolism in rats with a high fat diet

(2013) Ae Wha Ha et al.   Nutrition Research and Practice

Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease

(2013) Luca Valenti et al.   Oxidative Medicine and Cellular Longevity

Absorption of Vitamin A and Carotenoids by the Enterocyte: Focus on Transport Proteins

(2013) Emmanuelle Reboul   Nutrients

A Liver-Selective LXR Inverse Agonist That Suppresses Hepatic Steatosis

(2012) Kristine Griffett et al.   ACS Chemical Biology

Combination of fucoxanthin and conjugated linoleic acid attenuates body weight gain and improves lipid metabolism in high-fat diet-induced obese rats

(2012) Xiaojie Hu et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Naturally Occurring Eccentric Cleavage Products of Provitamin A β-Carotene Function as Antagonists of Retinoic Acid Receptors

(2012) Abdulkerim Eroglu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fucoxanthin Attenuates Rifampin-Induced Cytochrome P450 3A4 (CYP3A4) and Multiple Drug Resistance 1 (MDR1) Gene Expression Through Pregnane X Receptor (PXR)-Mediated Pathways in Human Hepatoma HepG2 and Colon Adenocarcinoma LS174T Cells

(2012) Cheng-Ling Liu et al.   Marine Drugs

The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes

(2012) Yaoyao Jia et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (HL-60) cells

(2011) Ponesakki Ganesan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways

(2011) Jessica L. Yecies et al.   Cell Metabolism

Liver X receptors bridge hepatic lipid metabolism and inflammation

(2011) Yuan LIU et al.   Journal of Digestive Diseases

The liver X receptor in hepatic stellate cells: A novel antifibrogenic target?

(2011) Ariane Mallat et al.   JOURNAL OF HEPATOLOGY

Carotenoids and apocarotenoids in cellular signaling related to cancer: A review

(2011) Yoav Sharoni et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

(2010) Elena Lima-Cabello et al.   CLINICAL SCIENCE

From the metabolic syndrome to NAFLD or vice versa?

(2010) Ester Vanni et al.   DIGESTIVE AND LIVER DISEASE

Liver X Receptor Signaling Is a Determinant of Stellate Cell Activation and Susceptibility to Fibrotic Liver Disease

(2010) Simon W. Beaven et al.   GASTROENTEROLOGY

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

(2010) Herbert Tilg et al.   HEPATOLOGY

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile

(2010) Ponesakki Ganesan et al.   PHYTOMEDICINE

Peroxisome Proliferator-Activated Receptor Alpha Target Genes

(2010) Maryam Rakhshandehroo et al.   PPAR Research

The effects of Xanthigen™in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat

(2009) M. Abidov et al.   DIABETES OBESITY & METABOLISM

Protective Effects of the Carotenoid Zeaxanthin in Experimental Nonalcoholic Steatohepatitis

(2009) Sherman M. Chamberlain et al.   DIGESTIVE DISEASES AND SCIENCES